Siham Mahgoub

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses”.

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

medRxiv(2022)10.1101/2022.07.12.22277336

N/A

1.6DataRank · unranked

30 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4

N/A

1.3DataRank · unranked

56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

Research Square(2023)10.21203/rs.3.rs-2653179/v1

N/A

0.372DataRank · unranked

5 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

medRxiv(2023)10.1101/2023.06.06.23290973

N/A

0DataRank · unranked

0 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +31 more

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications(2025)10.1038/s41467-025-55931-w

N/A

0DataRank · unranked

9 citations

Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Jing Wang +43 more

Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries

Nature Genetics(2022)10.1038/s41588-022-01113-z

N/A

0DataRank · unranked

140 citations

Megan L. Stanifer, Oscar Flórez-Vargas, Olusegun O. Onabajo, Brenen W. Papenberg, Muhammad Atif Zahoor +65 more

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial

Vaccine(2025)10.1016/j.vaccine.2025.127718

N/A

0DataRank · unranked

0 citations

Daniel S. Graciaa, Bo Zhang, Nadine Rouphael, Angela R Branche, Thomas Martin +13 more

Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad209

N/A

0DataRank · unranked

23 citations

Nadine Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer +31 more

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad323

N/A

0DataRank · unranked

3 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +80 more

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial

medRxiv(2023)10.1101/2023.01.31.23285306

N/A

0DataRank · unranked

1 citations

Nadine Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer +31 more